OACC
Oaktree Acquisition Corp. III Life Sciences
3월 12일 4:00 PM ET (한국 3/13 05:00)
$10.63
+0.00 +0.00%
| Index | - | P/E | 37.98 | EPS (ttm) | 0.28 | Insider Own | 19.52% | Shs Outstand | 0.02B | Perf Week | -0.37% |
| Market Cap | 0.26B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.02B | Perf Month | 0.09% |
| Enterprise Value | 0.26B | PEG | - | EPS next Q | - | Inst Own | 74.52% | Short Float | 0.25% | Perf Quarter | 0.28% |
| Income | 0.01B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.98 | Perf Half Y | 1.33% |
| Sales | 0.00B | P/B | 1.35 | EPS next 5Y | - | ROA | 6.82% | Short Interest | 0.05M | Perf YTD | 0.47% |
| Book/sh | 7.85 | P/C | 196.75 | EPS past 3/5Y | - | ROE | 7.13% | 52W High | -2.03% ($10.85) | Perf Year | 5.35% |
| Cash/sh | 0.05 | P/FCF | - | Sales past 3/5Y | - | ROIC | 3.56% | 52W Low | 5.88% ($10.04) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.19% 0.69% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.21 | EPS Q/Q | 3909.52% | Profit Margin | - | RSI (14) | 47.68 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.21 | Sales Q/Q | - | SMA20 | -0.31% ($10.66) | Beta | -0.06 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 0.03% ($10.63) | Rel Volume | 0 | Prev Close | $10.63 |
| Employees | 3 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 1.31% ($10.49) | Avg Volume(3M) | 0.05M | Price | $10.63 |
| IPO | 2024/12/16 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
뉴스 로딩 중...